Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about ...
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...
MedPage Today on MSN
FDA Flags Misleading Claims on Cancer Drug Made by Billionaire Owner of ImmunityBio
Patrick Soon-Shiong recently said Anktiva may be able to cure or prevent other cancers ...
KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.
Explore new findings on bladder cancer and inflammation's role in immune suppression. Discover insights to improve treatment.
Bladder cancer patients who have an early but aggressive form of the disease that’s unresponsive to the standard of care now have a new treatment option, an implanted Johnson & Johnson drug/device ...
A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy.
Diagnostic test based on urinary tumor markers hold promise for earlier or prompt detection of bladder cancer in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results